<DOC>
	<DOCNO>NCT01076361</DOCNO>
	<brief_summary>The Medtronic CapSure Epi Lead Post-approval Study ass long-term safety 4968 lead . This study part Medtronic System Longevity Study .</brief_summary>
	<brief_title>Model 4968 CAPTURE EPIÂ® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study</brief_title>
	<detailed_description>The Medtronic CapSure Epi Lead Post-approval Study conduct part requirement satisfy PMA condition approval Model 4968 lead . 100 subject ( adult pediatric ) 4968 lead follow minimum five year assess long-term safety lead .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Provision write informed consent and/or authorization access use health information subject appropriate legal guardian require institution 's Investigational Review Board , Medical Ethics Board , Research Ethics Board Availability implant , followup , productrelated event data Implanted Model 4968 Capsure Epi Lead Subjects receive implant Medtronic lead nonparticipating center implant data current status confirm within 30 day implant Subjects , inaccessible followup 4968 Postapproval study center Subjects implant Medtronic cardiac therapy device whose predetermined enrollment limit specific product exceed Subjects exclusion criterion require local law</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Epicardial</keyword>
	<keyword>Pacing Lead</keyword>
</DOC>